WO2000041540A2 - Herbal supplement for increased muscle strength and endurance for athletes - Google Patents

Herbal supplement for increased muscle strength and endurance for athletes Download PDF

Info

Publication number
WO2000041540A2
WO2000041540A2 PCT/US2000/000756 US0000756W WO0041540A2 WO 2000041540 A2 WO2000041540 A2 WO 2000041540A2 US 0000756 W US0000756 W US 0000756W WO 0041540 A2 WO0041540 A2 WO 0041540A2
Authority
WO
WIPO (PCT)
Prior art keywords
supplement
galanthamine
effective amount
muscle
endurance
Prior art date
Application number
PCT/US2000/000756
Other languages
French (fr)
Other versions
WO2000041540A3 (en
Inventor
Atanas Russinov Djananov
Tricia Grose
Original Assignee
Atanas Russinov Djananov
Tricia Grose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atanas Russinov Djananov, Tricia Grose filed Critical Atanas Russinov Djananov
Priority to EP00903268A priority Critical patent/EP1150695B1/en
Priority to AU25042/00A priority patent/AU2504200A/en
Publication of WO2000041540A2 publication Critical patent/WO2000041540A2/en
Publication of WO2000041540A3 publication Critical patent/WO2000041540A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a method of enhancing muscle strength and endurance in an athlete by administering a dietary supplement comprising an herbal extract or preparation containing galanthamine.
  • the nerve ending contains vesicles filled with acetylcholine, which is the main neurotransmitter in the human body.
  • the nerve impulse stimulates the vesicles to release acetylcholine into the synapse through the pores in the pre-synapse membrane.
  • the acetylcholine diffuses through the synapse gap very quickly (within 1 millisecond) and reaches the post-synapse membrane.
  • the acetylcholine depolarizes the post- synapse membrane, generating an electrical impulse which spreads along the muscle fiber and causes the muscle to contract.
  • This system of neuron-synapse- muscle operates as an "all-or-none" response, that is the stimulus must overcome an excitatory threshold in order for the signal to be transmitted and the muscle to contract.
  • the thresholds of excitation are different for different muscle motor units.
  • a motor unit is defined as the system of one motor nerve, its branches, the synapses located at the end of the branches, and the muscle fibers that are stimulated by the nerve. Both the threshold of excitation and the strength of the incoming nerve impulses can vary to a great degree. An increase in stimulus intensity may bring progressively more units to respond. In fact, improvement in strength, speed and endurance depend mainly on the body's ability to mobilize a greater number of muscle fibers in the contraction.
  • This ability is greatly influenced by temporary factors such as fatigue, stress level and food intake, and by long-term factors such as genetics, general fitness level, conditioning, hormonal levels, age, etc.
  • temporary factors such as fatigue, stress level and food intake, and by long-term factors such as genetics, general fitness level, conditioning, hormonal levels, age, etc.
  • genetics, general fitness level, conditioning, hormonal levels, age, etc. In the average non-training individual, only about 20-30% of the available muscle fibers become actively involved in the muscle contraction. This percentage is raised in professional athletes to about 40-50 % by regular and intensive workouts. Regular workouts, good nutrition and appropriate supplementation lead to an increase in the energy levels of the muscle cell, as well as to an extended growth and branching out of the capillary network, and the optimization of the work of numerous enzyme systems, etc., the result of all this being the lowering of the excitation threshold of the muscle fibers, which facilitates muscle contraction.
  • the passage of the impulses through the synapse is brief and unidirectional. Once acetylcholine has conveyed the nerve impulses across the synapse, it must be cleared from the gap. The body does this by breaking it down, or hydrolyzing it, to choline and acetyl, using acetylcholinesterase, or simply cholinesterase. Cholinesterase however eliminates some acetylcholine that has not reached the post-synapse membrane, therefore an 100% effective transmission of the nerve impulse through the synapse does not occur.
  • Galanthamine is a known acetylcholinesterase inhibitor. Galanthamine reversibly binds to acetylcholinesterase, inhibiting its action and resulting in an increase in local concentrations of acetylcholine. Galanthamine has been used in the treatment of different diseases of the nervous system such as Alzheimer's disease (U.S. Patent No. 5,958,903) and Parkinson's disease (5,965,571); the treatment of chronic fatigue syndrome (5,312,817); as an erectogenic agent in the treatment of male sexual dysfunction (5,177,070) as well as the treatment of glaucoma, myasthenia gravis and senile dementia.
  • Alzheimer's disease U.S. Patent No. 5,958,903
  • Parkinson's disease 5,965,571
  • the treatment of chronic fatigue syndrome 5,312,817
  • an erectogenic agent in the treatment of male sexual dysfunction (5,177,070) as well as the treatment of glaucoma, myasth
  • Galanthamine is typically used in pharmaceutical compositions in purified form and is obtained by complex chemical extractions from plant sources (U.S. Patent No. 5,877,172) or chemically synthesized (U.S. Patent Nos. 5,777,108 and 5,958,903). These processes may be disadvantageous in that they utilize undesirable chemicals such as chlorohydrocarbons and purification processes forming galanthamine salts.
  • the present invention provides a method for enhancing the sports performance of an athlete by administering to an athlete a composition comprising galanthamine as an active ingredient.
  • the galanthamine is administered in an amount effective to increase the strength, endurance and speed of muscle contraction, thereby improving the quality of an athlete's sport performance.
  • the galanthamine is preferably provided as a component of a dried whole plant or plant extract, most preferably Leucojum aestivum.
  • a daily dose of from about 2 - 15 mg of galanthamine unexpectedly improves the effectiveness of muscle performance, allowing athletes to achieve a high level performance in sports, particularly in strength and power events, such as weightlifting and body building, by increasing muscular quality, that is increasing the effectiveness of muscle fiber contraction.
  • the present invention also provides a novel herbal composition
  • a novel herbal composition comprising galanthamine as at least one active ingredient present in a powdered form of a whole plant extract that provides strength, endurance and speed in sport performance.
  • the composition also comprises a combination of naturally occurring substances such as B vitamins, Co-Q10, green tea and Ganoderma extracts, nonessential amino acids, antioxidants and minerals which in combination with the whole plant extract enhance the effectiveness of muscle performance.
  • the whole plant extract is of the plant
  • the whole plant extract is present in the herbal composition in an amount of from 0.1 - 3 wt%.
  • the present invention concerns novel dietary compositions, a method for their preparation, and a method of using the compositions for improvement of sports performance.
  • At least one of the active ingredients in the composition is most notably a cholinesterase inhibitor.
  • sports performance refers to the ability of the athlete's muscles to perform when participating in sports activities. Enhanced sports performance, strength, speed and endurance are measured by an increase in muscular contraction strength, increase in amplitude of muscle contraction, shortening of muscle reaction time between stimulation and contraction.
  • athlete refers to an individual who participates in sports at any level and who seeks to achieve an improved level of strength, speed and endurance in their performance.
  • the present invention is particularly beneficial to those athletes who are body builders. However, those athletes who are bicyclists, long distance runners, short distance runners will also benefit from the effects of the present invention.
  • An athlete may be hard training, that is, performs sports activities intensely more than three days a week or for competition.
  • An athlete may also be a fitness enthusiast who seeks to improve general health and well-being, improve energy levels, who works out for about 1-2 hours about 3 times a week.
  • a method of lowering the excitation threshold of muscle fibers and maintaining the lower level for improvement of strength, endurance and speed of muscle contraction is found to be greatly beneficial to those individuals seeking to improve the quality of their sports performance. While the dietary supplement may be used by individuals who are not in athletic training, the supplement is ideal for use by athletes to improve sports performance.
  • the invention provides a method of enhancing muscle performance by administering a dietary supplement comprising galanthamine.
  • Galanthamine is an alkaloid from the family of Amaryllidaceae that can be isolated from snowdrop Galanthus Nivalis, or preferably Leucojum aestivim.
  • Galanthamine can also be chemically synthesized using known methods (e.g., Bulgarian patent No. 25140) and may be provided as a salt, for example, in the form of galanthamine hydrobromide.
  • Galanthamine may be administered orally or parenterally, i.e. by injection.
  • the optimal daily dose is from about 2 to 15 mg. It can be taken up to 6 months without a break.
  • a typical regimen may be a daily dose administered for 50- 90 days, followed by a 30-40 day cessation of administration. For sports use, it is preferred that 5-10 mg is taken l 1/2 - 2 hours before workout. On non-training days, a maintenance dose of 2.5-5 mg, which can be divided into 2 intakes, set about 12 hours apart, is preferred.
  • the preferred dose range is 5-7 mg daily on active days with 3-4 mgs daily dose for maintenance on days off.
  • a daily dose of about 3-4 mg daily before a workout is preferred, with the same dose divided into two equal portions taken at 12 hour intervals on the off days.
  • Galanthamine hydrobromide may be administered for the purposes of the present invention in the form of capsules or caplets, although other conventional oral dosage forms such as tablets may also be used.
  • standard tablet or capsule making techniques may be employed.
  • the inventors have found that the whole plant extract of Leucojum aestivum. in combination with the coenzyme Co- Q10 plus vitamin B and other herbal extracts, works synergistically to promote improved sports performance.
  • At least one of the active ingredients in the whole plant extract, galanthamine, in its capacity as an acetylcholinesterase inhibitor increases muscle resistance to fatigue by maintaining a lower excitation threshold level for longer periods of time.
  • the active ingredients secure stronger impulses which, when transmitted to the muscles, generate stronger muscle contractions.
  • Each of the constituents of the combined herbal preparation of the invention has an individual tendancy to enhance physical well being.
  • the combination of Leucojum aestivum. coenzyme Co-Q10 plus vitamin Bs (including niacin, thiamine vitamin B 12 and vitamin B complex) and other herbal extracts when administered in proper concentration, stimulate stronger muscle fiber contractions to allow for more sustained and effective physical activity.
  • the ingredients may further stimulate the release of acetylcholine in the neuron endings and increase the sensitivity of the post-synapse membranes.
  • a process for preparing the whole plant extract Leucojum aestivim is described as follows: the mucilage is removed from intact plants, the remaining plant material is pulverized or finely chopped in a blender, the pulverized plant material is steam distilled, and then triple washed with water. The treated plant material is then combined with the washings and the mucilage to form the whole plant extract.
  • the whole plant extract may be used unfiltered, or may be filtered through a Whatman filter. Alternatively the resulting whole plant extract may be dried to a powder by air drying at room temperature or accelerated drying at 37 °C.
  • the whole plant extract is preferably stored in a dark container at room temperature in a moisture-free environment until used.
  • the supplement may further contain ingredients that improve oxygen metabolism, antioxidants, factors which directly or indirectly are related to radical scavengers or improve cardiac function. While any of these constituents taken alone would be insufficient to produce the desired result, in combination they work synergistically to produce significant enhancement of physical sports activity. The constituents are not toxic in the amounts provided and have no known side-effects.
  • the composition may thus further include a combination of naturally occurring substances such as herbs, growth factors, enzymes such as coenzyme Q10 (CoQ10) chemically known as 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4- benzoquinone, a fat soluble quinone, which is an essential component of the mitochondrial respiratory chain and may be important in producing energy for all the body's activities; hormones; amino acids; trace elements, vitamins and minerals, particularly in amounts 100-500% of RDA; compounds such as antioxidants present in extracts of Chinese plants and herbs such as green tea and fungi of the genus Ganoderma and other nonessential nutrients such as N-acetyl cysteine (NAC), a non-essential amino acid, believed to benefit brain function.
  • CoQ10 coenzyme Q10
  • the composition can further include choline, a component of the neurotransmitter acetylcholine, in supplemental doses in the range of about 50-200mg, which may increase the level of acetylcholine produced, assist in maintaining the integrity of neuronal membranes and enhance synaptic transmissions; and L-carnitine, a metabolic cofactor, which promotes neurological recovery from trauma.
  • choline a component of the neurotransmitter acetylcholine
  • supplemental doses in the range of about 50-200mg, which may increase the level of acetylcholine produced, assist in maintaining the integrity of neuronal membranes and enhance synaptic transmissions
  • L-carnitine a metabolic cofactor, which promotes neurological recovery from trauma.
  • Vitamin B 12 (equivalent to about 200% RDA) 5 mg (0.1 wt%) Vitamin B 15 mg (3.1 wt%) Green tea 12.5 mg (2.6 wt%) Ganoderma 320 mg (65.6 wt%) N-acetylcysteine (NAC) 40 mg (8.2 wt%) L-carnitine 30 mg (6.2 wt%) C0-Q10
  • the preferred dosage form is a capsule. In this manner the free flowing powders of the herbal extracts and other components in the composition of the invention are readily absorbed into the body.
  • EXAMPLE In order to demonstrate the effect of the method of the present invention on athlete strength and endurance the following study is conducted: 30 healthy individuals, both male and female, ages 18-28, are separated into 2 groups, 15 persons each, to observe the changes in their strength and endurance after administration of galanthamine and regular physical training. All subjects are athletes who have exercised regularly in the gym for 1 to 3 years. During the 3 week test period, all subjects train about 4 times a week with a special exercise program forthe first week as described below, supplemented with the subjects' own preferred training schedule. Strength and endurance were observed through 6 basic exercises involving the major muscle groups as follows: 1. Bench press-for the chest muscles
  • the dosage of galanthamine is 7.5 mg daily taken with a meal 1.5 - 2 hours before the workout on training days and 5 mg daily on non-training days divided into two equal portions taken in the morning and in the afternoon.
  • the STRENGTH GROUP a. The initial level. Before administration of galanthamine the initial strength level of each subject is determined and is defined as the maximum weight a subject is able to lift in all 6 exercises. b. The training schedule.
  • the subjects use a split training method, that is they alternate on one day training their chest, back and shoulder muscles (performing exercises #1 , 2 and 3, respectively) and the next day train their biceps, triceps and legs (exercises #4, 5 and 6, respectively).
  • the subjects do 5-6 sets in each exercise using a pyramidal principle for increasing their strength, i.e. they start every exercise doing 10-15 repetitions using a middle weight, then increase the weight gradually, being able to do fewer repetitions, until the maximum weight they are able to lift for one repetition with difficulty is reached. 2 sets are then performed using the same or 5-10% less weight. This maximum weight is considered the "record forthe day", and is compared to the initial level. c. The results.
  • the ENDURANCE GROUP a. The initial level. The subjects establish the initial maximum weight they are able to lift in the 6 exercises in the same manner as the strength group. The subjects perform as many repetitions as possible using these weights and the number of the maximum repetitions is considered to be the base initial endurance level. Endurance is estimated as 50% of the maximum weight able to be lifted.

Abstract

Athletic performance may be improved by administering a composition comprising galanthamine as an active ingredient to an athlete before and during sports activities. Also provided is a herbal sports performance composition comprising whole plant extract of Leucojum aestivum.

Description

HERBAL SUPPLEMENT FOR INCREASED MUSCLE STRENGTH AND ENDURANCE FOR ATHLETES
Field of the Invention
The present invention relates to a method of enhancing muscle strength and endurance in an athlete by administering a dietary supplement comprising an herbal extract or preparation containing galanthamine.
Background of the Invention
Motive nerve impulses are transmitted as electrical signals along a motorneuron until they reach the neuron ending located on a muscle. The nerve ending contains vesicles filled with acetylcholine, which is the main neurotransmitter in the human body. The nerve impulse stimulates the vesicles to release acetylcholine into the synapse through the pores in the pre-synapse membrane. The acetylcholine diffuses through the synapse gap very quickly (within 1 millisecond) and reaches the post-synapse membrane. The acetylcholine depolarizes the post- synapse membrane, generating an electrical impulse which spreads along the muscle fiber and causes the muscle to contract. This system of neuron-synapse- muscle operates as an "all-or-none" response, that is the stimulus must overcome an excitatory threshold in order for the signal to be transmitted and the muscle to contract. The thresholds of excitation are different for different muscle motor units. A motor unit is defined as the system of one motor nerve, its branches, the synapses located at the end of the branches, and the muscle fibers that are stimulated by the nerve. Both the threshold of excitation and the strength of the incoming nerve impulses can vary to a great degree. An increase in stimulus intensity may bring progressively more units to respond. In fact, improvement in strength, speed and endurance depend mainly on the body's ability to mobilize a greater number of muscle fibers in the contraction. This ability is greatly influenced by temporary factors such as fatigue, stress level and food intake, and by long-term factors such as genetics, general fitness level, conditioning, hormonal levels, age, etc. In the average non-training individual, only about 20-30% of the available muscle fibers become actively involved in the muscle contraction. This percentage is raised in professional athletes to about 40-50 % by regular and intensive workouts. Regular workouts, good nutrition and appropriate supplementation lead to an increase in the energy levels of the muscle cell, as well as to an extended growth and branching out of the capillary network, and the optimization of the work of numerous enzyme systems, etc., the result of all this being the lowering of the excitation threshold of the muscle fibers, which facilitates muscle contraction.
The passage of the impulses through the synapse is brief and unidirectional. Once acetylcholine has conveyed the nerve impulses across the synapse, it must be cleared from the gap. The body does this by breaking it down, or hydrolyzing it, to choline and acetyl, using acetylcholinesterase, or simply cholinesterase. Cholinesterase however eliminates some acetylcholine that has not reached the post-synapse membrane, therefore an 100% effective transmission of the nerve impulse through the synapse does not occur. In addition, after continuous or repetitive movement or exercise, fatigue reduces the strength and duration of the impulses generated, and stimulates the release of the inhibitory neurotransmitter gamma aminobutyric acid, which overpolarizes the post-synapse membrane. The amount of acetylcholine released by the pre-synapse membrane also decreases. As a result of these factors, the energy level of the muscle cell is decreased and the excitation threshold becomes more difficult to overcome.
Galanthamine is a known acetylcholinesterase inhibitor. Galanthamine reversibly binds to acetylcholinesterase, inhibiting its action and resulting in an increase in local concentrations of acetylcholine. Galanthamine has been used in the treatment of different diseases of the nervous system such as Alzheimer's disease (U.S. Patent No. 5,958,903) and Parkinson's disease (5,965,571); the treatment of chronic fatigue syndrome (5,312,817); as an erectogenic agent in the treatment of male sexual dysfunction (5,177,070) as well as the treatment of glaucoma, myasthenia gravis and senile dementia.
Galanthamine is typically used in pharmaceutical compositions in purified form and is obtained by complex chemical extractions from plant sources (U.S. Patent No. 5,877,172) or chemically synthesized (U.S. Patent Nos. 5,777,108 and 5,958,903). These processes may be disadvantageous in that they utilize undesirable chemicals such as chlorohydrocarbons and purification processes forming galanthamine salts.
There is great interest in improving the strength, speed and endurance of physical performance, particularly in athletes. One factor which enables athletes to achieve high level performance in sports, particularly in strength and power events, such as weightlifting and body building, is to increase muscular quality, that is to increase the effectiveness of muscle fiber contraction. An inexpensive, non- toxic preparation, preferably in an herbal formulation containing a whole plant extract that enhances the performance of muscle contraction in individuals, thereby improving physical performance, has heretofore not been disclosed.
SUMMARY OF THE INVENTION
The present invention provides a method for enhancing the sports performance of an athlete by administering to an athlete a composition comprising galanthamine as an active ingredient. The galanthamine is administered in an amount effective to increase the strength, endurance and speed of muscle contraction, thereby improving the quality of an athlete's sport performance. The galanthamine is preferably provided as a component of a dried whole plant or plant extract, most preferably Leucojum aestivum.
The applicants have found that a daily dose of from about 2 - 15 mg of galanthamine unexpectedly improves the effectiveness of muscle performance, allowing athletes to achieve a high level performance in sports, particularly in strength and power events, such as weightlifting and body building, by increasing muscular quality, that is increasing the effectiveness of muscle fiber contraction.
The present invention also provides a novel herbal composition comprising galanthamine as at least one active ingredient present in a powdered form of a whole plant extract that provides strength, endurance and speed in sport performance. In one embodiment, the composition also comprises a combination of naturally occurring substances such as B vitamins, Co-Q10, green tea and Ganoderma extracts, nonessential amino acids, antioxidants and minerals which in combination with the whole plant extract enhance the effectiveness of muscle performance. In a preferred embodiment the whole plant extract is of the plant
Leucojum aestivum. The whole plant extract is present in the herbal composition in an amount of from 0.1 - 3 wt%.
DETAILED DESCRIPTION OF THE INVENTION
The present invention concerns novel dietary compositions, a method for their preparation, and a method of using the compositions for improvement of sports performance. At least one of the active ingredients in the composition is most notably a cholinesterase inhibitor.
The term "sports performance" as used herein, refers to the ability of the athlete's muscles to perform when participating in sports activities. Enhanced sports performance, strength, speed and endurance are measured by an increase in muscular contraction strength, increase in amplitude of muscle contraction, shortening of muscle reaction time between stimulation and contraction.
The term "athlete" refers to an individual who participates in sports at any level and who seeks to achieve an improved level of strength, speed and endurance in their performance. The present invention is particularly beneficial to those athletes who are body builders. However, those athletes who are bicyclists, long distance runners, short distance runners will also benefit from the effects of the present invention. An athlete may be hard training, that is, performs sports activities intensely more than three days a week or for competition. An athlete may also be a fitness enthusiast who seeks to improve general health and well-being, improve energy levels, who works out for about 1-2 hours about 3 times a week. A method of lowering the excitation threshold of muscle fibers and maintaining the lower level for improvement of strength, endurance and speed of muscle contraction is found to be greatly beneficial to those individuals seeking to improve the quality of their sports performance. While the dietary supplement may be used by individuals who are not in athletic training, the supplement is ideal for use by athletes to improve sports performance.
Enhanced sports performance in manifested by the ability to overcome muscle fatigue, ability to maintain activity for longer periods of time, and have a more effective workout. It is believed that galanthamine improves athletic performance through its properties of increasing the strength of muscle contractions, maintaining a lower excitation threshold for a longer period of time delaying the onset of fatigue in muscles, and decreasing the latent period (reaction time) for a muscle contraction, so that the muscles can be stimulated more often and work more. This may also be beneficial to physical activity involving repetitive motion. In one aspect, the invention provides a method of enhancing muscle performance by administering a dietary supplement comprising galanthamine. Galanthamine is an alkaloid from the family of Amaryllidaceae that can be isolated from snowdrop Galanthus Nivalis, or preferably Leucojum aestivim. Galanthamine can also be chemically synthesized using known methods (e.g., Bulgarian patent No. 25140) and may be provided as a salt, for example, in the form of galanthamine hydrobromide.
Galanthamine may be administered orally or parenterally, i.e. by injection. The optimal daily dose is from about 2 to 15 mg. It can be taken up to 6 months without a break. A typical regimen may be a daily dose administered for 50- 90 days, followed by a 30-40 day cessation of administration. For sports use, it is preferred that 5-10 mg is taken l1/2 - 2 hours before workout. On non-training days, a maintenance dose of 2.5-5 mg, which can be divided into 2 intakes, set about 12 hours apart, is preferred.
For the hard training athlete the preferred dose range is 5-7 mg daily on active days with 3-4 mgs daily dose for maintenance on days off. For fitness enthusiasts a daily dose of about 3-4 mg daily before a workout is preferred, with the same dose divided into two equal portions taken at 12 hour intervals on the off days. Galanthamine hydrobromide may be administered for the purposes of the present invention in the form of capsules or caplets, although other conventional oral dosage forms such as tablets may also be used. In preparing capsules or tablets, standard tablet or capsule making techniques may be employed. In another aspect of the invention, the inventors have found that the whole plant extract of Leucojum aestivum. in combination with the coenzyme Co- Q10 plus vitamin B and other herbal extracts, works synergistically to promote improved sports performance. It is believed that at least one of the active ingredients in the whole plant extract, galanthamine, in its capacity as an acetylcholinesterase inhibitor, increases muscle resistance to fatigue by maintaining a lower excitation threshold level for longer periods of time. The active ingredients secure stronger impulses which, when transmitted to the muscles, generate stronger muscle contractions. Each of the constituents of the combined herbal preparation of the invention has an individual tendancy to enhance physical well being. However, the combination of Leucojum aestivum. coenzyme Co-Q10 plus vitamin Bs ( including niacin, thiamine vitamin B12 and vitamin B complex) and other herbal extracts, when administered in proper concentration, stimulate stronger muscle fiber contractions to allow for more sustained and effective physical activity. The ingredients may further stimulate the release of acetylcholine in the neuron endings and increase the sensitivity of the post-synapse membranes.
Although one of the active ingredients, galanthamine, found in the whole plant extract of Leucojum aestivim can be synthesized by known methods, Applicants have found that using the whole plant extract provides beneficial results. It is believed that the additional components contained within the plant cell wall as well as the other ingredients contained in the composition as described herein provide an unexpected synergistic effect on muscle performance. An added advantage is the use of herbal based compositions providing many beneficial results. This is particularly advantageous for those individuals reluctant to use pharmaceuticals containing synthetic chemicals because of potential side effects of long term use or where no nonprescription remedy is available.
For purposes of the invention, a process for preparing the whole plant extract Leucojum aestivim is described as follows: the mucilage is removed from intact plants, the remaining plant material is pulverized or finely chopped in a blender, the pulverized plant material is steam distilled, and then triple washed with water. The treated plant material is then combined with the washings and the mucilage to form the whole plant extract. The whole plant extract may be used unfiltered, or may be filtered through a Whatman filter. Alternatively the resulting whole plant extract may be dried to a powder by air drying at room temperature or accelerated drying at 37 °C. The whole plant extract is preferably stored in a dark container at room temperature in a moisture-free environment until used.
Additional organic ingredients may be added to activate incidental benefits. The supplement may further contain ingredients that improve oxygen metabolism, antioxidants, factors which directly or indirectly are related to radical scavengers or improve cardiac function. While any of these constituents taken alone would be insufficient to produce the desired result, in combination they work synergistically to produce significant enhancement of physical sports activity. The constituents are not toxic in the amounts provided and have no known side-effects.
The composition may thus further include a combination of naturally occurring substances such as herbs, growth factors, enzymes such as coenzyme Q10 (CoQ10) chemically known as 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4- benzoquinone, a fat soluble quinone, which is an essential component of the mitochondrial respiratory chain and may be important in producing energy for all the body's activities; hormones; amino acids; trace elements, vitamins and minerals, particularly in amounts 100-500% of RDA; compounds such as antioxidants present in extracts of Chinese plants and herbs such as green tea and fungi of the genus Ganoderma and other nonessential nutrients such as N-acetyl cysteine (NAC), a non-essential amino acid, believed to benefit brain function. The composition can further include choline, a component of the neurotransmitter acetylcholine, in supplemental doses in the range of about 50-200mg, which may increase the level of acetylcholine produced, assist in maintaining the integrity of neuronal membranes and enhance synaptic transmissions; and L-carnitine, a metabolic cofactor, which promotes neurological recovery from trauma. These ingredients in combination with the active enhance the speed, endurance and strength of muscle performance, particularly in an athlete. Forthe herbal preparation, the composition of the invention comprises the ingredients provided in Table 1.
Table 1
Figure imgf000010_0001
The desired effect is best achieved with a dose comprising the following preferred concentrations:
2.5 mg (0.5 wt%) of the whole plant extract of Leucojum aestivum 25 mg (5.1 wt%) Inositol Hexanicotinate 12.5 mg (2.6 wt%) Thiamine
0.012mg (0.00045 wt%) Vitamin B12 (equivalent to about 200% RDA) 5 mg (0.1 wt%) Vitamin B 15 mg (3.1 wt%) Green tea 12.5 mg (2.6 wt%) Ganoderma 320 mg (65.6 wt%) N-acetylcysteine (NAC) 40 mg (8.2 wt%) L-carnitine 30 mg (6.2 wt%) C0-Q10
25 mg (5.1 wt%) calcium (as calcium pantothenate).
In the case of the herbal composition of the invention, the preferred dosage form is a capsule. In this manner the free flowing powders of the herbal extracts and other components in the composition of the invention are readily absorbed into the body.
The invention can be better understood by reference to the following Example, which is provided by way of illustration and not by way of limitation.
EXAMPLE In order to demonstrate the effect of the method of the present invention on athlete strength and endurance the following study is conducted: 30 healthy individuals, both male and female, ages 18-28, are separated into 2 groups, 15 persons each, to observe the changes in their strength and endurance after administration of galanthamine and regular physical training. All subjects are athletes who have exercised regularly in the gym for 1 to 3 years. During the 3 week test period, all subjects train about 4 times a week with a special exercise program forthe first week as described below, supplemented with the subjects' own preferred training schedule. Strength and endurance were observed through 6 basic exercises involving the major muscle groups as follows: 1. Bench press-for the chest muscles
2. Lateral pull downs- for the back muscles
3. Press behind neck-for the shoulder muscles
4. Bicep curls
5. Tricep pushdowns 6. Squats-for the leg muscles
10 participants in each group take galanthamine, the other 5 take a placebo. The dosage of galanthamine is 7.5 mg daily taken with a meal 1.5 - 2 hours before the workout on training days and 5 mg daily on non-training days divided into two equal portions taken in the morning and in the afternoon. 2. THE STRENGTH GROUP. a. The initial level. Before administration of galanthamine the initial strength level of each subject is determined and is defined as the maximum weight a subject is able to lift in all 6 exercises. b. The training schedule. The subjects use a split training method, that is they alternate on one day training their chest, back and shoulder muscles (performing exercises #1 , 2 and 3, respectively) and the next day train their biceps, triceps and legs (exercises #4, 5 and 6, respectively). The subjects do 5-6 sets in each exercise using a pyramidal principle for increasing their strength, i.e. they start every exercise doing 10-15 repetitions using a middle weight, then increase the weight gradually, being able to do fewer repetitions, until the maximum weight they are able to lift for one repetition with difficulty is reached. 2 sets are then performed using the same or 5-10% less weight. This maximum weight is considered the "record forthe day", and is compared to the initial level. c. The results. An increase in strength is observed almost immediately after administration of galanthamine. After 1 week, the average increase in strength is about 4 - 7%. After the initial increase, strength increases at a slower rate and by the third week, increases by a total of 10-13%. The subjects taking the placebo show an approximate 1 - 3% increase in strength within the period of the trial, as a result of exercise alone. Athletes who continue to take galanthamine for up to 3 months report an increase in strength of over 20% during the entire period.
3. THE ENDURANCE GROUP. a. The initial level. The subjects establish the initial maximum weight they are able to lift in the 6 exercises in the same manner as the strength group. The subjects perform as many repetitions as possible using these weights and the number of the maximum repetitions is considered to be the base initial endurance level. Endurance is estimated as 50% of the maximum weight able to be lifted. b. The training schedule. Exercises 1 , 2 and 3 are performed on one day and exercises # 4, 5 and 6 on alternate days. The subjects use only one weight in each exercise but gradually increase the number of repetitions. The subjects perform 10 repetitions in the first set, 20 repetitions in the second set (both as a warm-up) and as many repetitions as possible in the third set. After a 1-2 minute rest, 2 more sets are performed, while the subjects try to add at least 1-2 repetitions more than the previous set. The maximum number of repetitions is compared with the initial level, b. The results. An improvement in endurance in the subjects taking galanthamine is observed almost immediately. After the first week, the average endurance increases by 11% and by the end of the trial, after 3 weeks of treatment with galanthamine the average endurance increases by 24%. The subjects taking the placebo show only a 5% increase in endurance for the entire period.
3.CONCLUSION.
The administration of galanthamine for 3 weeks increases the strength and the endurance of active athletes.
The present invention is not to be limited in scope by the specific embodiments described herein. Indeed, various modifications of the invention in addition to those described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are intended to fall within the scope of the appended claims. Various patents, patent applications, and publications are cited herein, the disclosures of which are incorporated by reference in their entireties.

Claims

WHAT IS CLAIMED IS:
1. A method for improving the effectiveness of muscle performance in an athlete which method comprises administering to an athlete an effective amount of galanthamine.
2. The method of claim 1 wherein the galanthamine is administered at least one hour before participation in an athletic activity.
3. The method of claim 1 wherein the galanthamine is administered in a daily dose of from about 2 mg to 15 mg.
4. The method of claim 1 wherein galanthamine is administered in the form of its hydrobromide salt.
5. A daily dietary supplement for improving the effectiveness of muscle performance in an athlete, said supplement comprising an effective amount of galanthamine; an effective amount of Co-Q10; an effective amount of B vitamins; an effective amount of non-essential amino acids; and an effective amount of antioxidants.
6. The supplement of claim 5 wherein the galanthamine is present in a whole plant extract.
7. The supplement of claim 6 wherein the plant is Leucojum aestivum.
8. The supplement of claim 7 wherein the whole plant extract of Leucojum aestivum is present in an amount of about 0.25-4.5wt %.
9. The supplement of claim 8 where in the whole plant extract of Leucojum aestivum is present in an amount of about 0.5% wt.
10. The supplement of claim 5 wherein the effective amount of Co-Q 10 is about 4.0-7.3 wt %.
11. The supplement of claim 10 wherein the effective amount of Co-Q 10 is about 6.2 wt %.
12. The supplement of claim 5 wherein the effective amount of B vitamins is in the amount of about 3.55-10.8 wt %.
13. The supplement of claim 12 wherein the effective amount of B vitamins is about 7.8 wt %.
14. The supplement of claim 5, further comprising green tea, Ganoderma, N-acetylcysteine, L-carnitine and calcium.
15. An herbal composition for improving the effectiveness of muscle performance in an athlete, comprising about 0.5 wt% of whole plant extract of Leucojum aestivum; about 5.1 wt% inositol hexanicotinate; about 2.6 wt% thiamine; about 0.1 wt% Vitamin Bs; about 3.1 wt% green tea; about 2.6 wt% Ganoderma; about 65.6 wt% N-acetylcysteine; about 8.2 wt% L-carnitine; about 6.2 wt% Co-Q10; and about 5.1 wt% calcium pantothenate.
PCT/US2000/000756 1999-01-11 2000-01-11 Herbal supplement for increased muscle strength and endurance for athletes WO2000041540A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00903268A EP1150695B1 (en) 1999-01-11 2000-01-11 Herbal supplement for increased muscle strength and endurance for athletes
AU25042/00A AU2504200A (en) 1999-01-11 2000-01-11 Herbal supplement for increased muscle strength and endurance for athletes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11536699P 1999-01-11 1999-01-11
US60/115,366 1999-01-11

Publications (2)

Publication Number Publication Date
WO2000041540A2 true WO2000041540A2 (en) 2000-07-20
WO2000041540A3 WO2000041540A3 (en) 2000-11-23

Family

ID=22360928

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/000756 WO2000041540A2 (en) 1999-01-11 2000-01-11 Herbal supplement for increased muscle strength and endurance for athletes

Country Status (6)

Country Link
US (2) US6159476A (en)
EP (1) EP1150695B1 (en)
AT (1) ATE355066T1 (en)
AU (1) AU2504200A (en)
BG (1) BG65399B1 (en)
WO (1) WO2000041540A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171332A1 (en) * 2008-09-11 2011-07-14 I.B.R. Israeli Biotechnology Research Ltd. Leucojum bulb extracts and use thereof
WO2014134692A1 (en) 2013-03-07 2014-09-12 Berbee Beheer Bv. Extract of hippeastrum papilio rich in galanthamine
US20210267918A1 (en) * 2018-06-29 2021-09-02 Rejuvenate Biomed Pharmaceutical combination for use in age-related and/or degenerative diseases

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
US6426097B2 (en) * 2000-01-28 2002-07-30 Herbaceuticals Inc. Herbal supplement for cognitive related impairment due to estrogen loss
US6391332B1 (en) * 2000-04-20 2002-05-21 Baxter International, Inc. Therapeutic micronutrient composition for severe trauma, burns and critical illness
CA2469486A1 (en) * 2001-12-10 2003-06-19 Washington University Diagnostic for early stage alzheimer's disease
US6652891B2 (en) 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
US7989009B2 (en) * 2006-02-02 2011-08-02 Advocare International, L.P. Composition and method for promoting weight loss
US8764447B2 (en) 2010-06-07 2014-07-01 J. Harold Fieldberg Drug-free method and system for reduction of lactic acid while training athletes using ph balancing

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221827A1 (en) * 1982-06-09 1983-12-15 DSO Pharmachim, Sofija BIOSTIMULATING AGENT
US5585375A (en) * 1994-07-01 1996-12-17 Davis; Bonnie M. Method for alleviating jet lag

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2108880A1 (en) * 1991-05-14 1992-11-15 Ernir Snorrason Treatment of fatigue syndrome with cholinesterase inhibitors
US5177070A (en) * 1991-11-15 1993-01-05 Ciba-Geigy Corporation Method of treating physiologic male erectile impotence
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
DE19509663A1 (en) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Process for the isolation of galanthamine
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
US5965571A (en) * 1996-08-22 1999-10-12 New York University Cholinesterase inhibitors for treatment of Parkinson's disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221827A1 (en) * 1982-06-09 1983-12-15 DSO Pharmachim, Sofija BIOSTIMULATING AGENT
US5585375A (en) * 1994-07-01 1996-12-17 Davis; Bonnie M. Method for alleviating jet lag

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DIMITROV T., ET AL.: "Study of the effect of nivalin and its combination with B-vitamins on hypoxia and on the physical endurance of experimental animals" DOKL. BOLG. AKAD. NAUK., vol. 41, no. 7, 1988, pages 141-144, XP000915624 sofia, bulg. *
HARVEY A. L.: "The pharmacology of galanthamine and its analogues" PHARMACOLOGY AND THERAPEUTICS, vol. 68, no. 1, 1995, pages 113-128, XP000915592 *
IRWIN R. L., ET AL.: "The activity of galanthamine and related compounds on muscle" ARCH. INT. PHARMACODYN., vol. 127, no. 3-4, 1 September 1960 (1960-09-01), pages 314-330, XP000915620 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171332A1 (en) * 2008-09-11 2011-07-14 I.B.R. Israeli Biotechnology Research Ltd. Leucojum bulb extracts and use thereof
WO2014134692A1 (en) 2013-03-07 2014-09-12 Berbee Beheer Bv. Extract of hippeastrum papilio rich in galanthamine
US20210267918A1 (en) * 2018-06-29 2021-09-02 Rejuvenate Biomed Pharmaceutical combination for use in age-related and/or degenerative diseases

Also Published As

Publication number Publication date
EP1150695B1 (en) 2007-02-28
US20030139392A1 (en) 2003-07-24
ATE355066T1 (en) 2006-03-15
EP1150695A2 (en) 2001-11-07
BG65399B1 (en) 2008-06-30
US6159476A (en) 2000-12-12
BG105796A (en) 2002-06-28
AU2504200A (en) 2000-08-01
WO2000041540A3 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
Williams Nutritional ergogenics in athletics
US7338672B2 (en) Herbal supplement for cognitive related impairment due to estrogen loss
US6159476A (en) Herbal supplement for increased muscle strength and endurance for athletes
CN101742999B (en) Anti-fatigue agent and oral composition each comprising and rographolide as active ingredient
CN1625406A (en) Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
CN108308493A (en) A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing
US6525027B2 (en) Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
CN105495582A (en) Anti-fatigue and restorative health-care food amino acid composition
US6465018B1 (en) Dietary supplement for increasing energy, strength, and immune function
CN111228468A (en) Liquid preparation with effects of improving exercise endurance and helping exercise recovery
CN103704711B (en) Granules with anti-fatigue and health-care function
US8603546B2 (en) Herbal supplement for increased muscle strength and endurance for athletes
RU2376888C2 (en) Dietary supplement
CN103110114B (en) Beta-alanine-containing composition for endurance increase, and preparation thereof
Dragoo et al. Effects of a caffeine-containing transdermal energy patch on aerobic and anaerobic exercise performance
CN101331950A (en) Nutritional supplement for increasing sports break-out force
CN102631503A (en) Antifatigue traditional Chinese medicine composition and preparation method thereof
CA2398747C (en) Herbal supplement containing galanthamine for treating symptoms of estrogen-deficiency
Lamoreau et al. Can Herbs Improve Endurance? Adaptogens and Athletic Performance
WO2022271813A1 (en) Compositions containing adenosine triphosphate (atp) and methods of use for cognitive function
Anderson Beneficial roles of caffeine in sports nutrition and beverage formulations
CN117581990A (en) Baicalin composition for improving endurance and preparation process thereof
Stewart How Does Caffeine Supplementation Affect Muscular Performance in Adolescent Males?
CN110709076A (en) Ammonia metabolism promoter
GORCHAKOVA SCOPUS: 6602434760

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2000903268

Country of ref document: EP

ENP Entry into the national phase

Ref country code: BG

Ref document number: 2000 105796

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000903268

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000903268

Country of ref document: EP